MedTrace Logo

Healthy Starts: Repeated Exposure Pilot

NCT05639361 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 180

Last updated 2023-05-10

No results posted yet for this study

Summary

Decades of research have established that providing repeated exposure to new foods is the most robust strategy for promoting children's acceptance of new foods (1). However, there is little guidance on how best to translate this recommendation into everyday family life about how often to introduce children to new foods. We propose to conduct a proof-of-concept randomized trial that will evaluate three different schedules of repeated exposure to a novel vegetable, which will help to identify the optimal "pacing" of repeated exposure to promote children's acceptance (i.e., intake) of new vegetables. Here we define "pacing" as how often (every day, every few days, etc.) and across what interval of time (days, weeks, months) repeated exposure is effective for infants to learn to accept a novel food.

Conditions

  • Feeding Behavior

Interventions

BEHAVIORAL

Repeated Exposure

Caregivers will be asked to offer a novel vegetable to their infant/toddler 10 times at home according to the schedule of repeated exposure to which they are randomized.

Sponsors & Collaborators

  • Temple University

    collaborator OTHER

  • Vitamix Foundation

    collaborator UNKNOWN

  • University of Colorado, Denver

    lead OTHER

Principal Investigators

  • Katherine J Barrett, PhD · University of Colorado, Denver

  • Susan L Johnson, PhD · University of Colorado, Denver

Eligibility

Min Age
9 Months
Max Age
12 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-04-01
Primary Completion
2024-06-30
Completion
2024-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05639361 on ClinicalTrials.gov